Markedly increased Rho-kinase activity in circulating leukocytes in patients with chronic heart failure
dc.contributor.author | Paz Ocaranza, Maria | |
dc.contributor.author | Gabrielli, Luigi | |
dc.contributor.author | Mora, Italo | |
dc.contributor.author | Garcia, Lorena | |
dc.contributor.author | McNab, Paul | |
dc.contributor.author | Godoy, Ivan | |
dc.contributor.author | Braun, Sandra | |
dc.contributor.author | Cordova, Samuel | |
dc.contributor.author | Castro, Pablo | |
dc.contributor.author | Novoa, Ulises | |
dc.contributor.author | Chiong, Mario | |
dc.contributor.author | Lavandero, Sergio | |
dc.contributor.author | Jalil, Jorge E. | |
dc.date.accessioned | 2024-01-10T13:50:16Z | |
dc.date.available | 2024-01-10T13:50:16Z | |
dc.date.issued | 2011 | |
dc.description.abstract | Background The small guanosine triphosphatase Rho and its target Rho-kinase have significant roles in experimental remodeling and ventricular dysfunction, but no data are available on Rho-kinase activation in patients with heart failure (HF). We hypothesized that, in patients with chronic HF, Rho-kinase in circulating leukocytes is activated and related to left ventricular (LV) remodeling and dysfunction. | |
dc.description.abstract | Methods Accordingly, Rho-kinase activity, assessed by the levels of phosphorylated to total myosin light chain phosphatase 1 (MYPT1-P/T) in circulating leukocytes, and echocardiographic LV function data were compared between patients with HF New York Heart Association functional class II or III due to systolic dysfunction (n = 17), healthy controls (n = 17), and hypertensive patients without HF (n = 17). | |
dc.description.abstract | Results In the control subjects, mean MYPT1-P/T ratio was 1.2 +/- 0.2 (it was similar in the hypertensive patients without HF), whereas in patients with HF, it was significantly increased by > 100-fold (P < .001). Both MYPT1-P/T and log MYPT1-P/T ratios were inversely correlated with ejection fraction (r = -0.54, P < .03 and r = -0.86, P < .001, respectively). Furthermore, in patients with HF with LV end-diastolic diameter < 60 mm, MYPT1-P/T ratio was 35.8 +/- 18.1, whereas it was significantly higher in patients with LV diameter >= 60 mm (P < .05). | |
dc.description.abstract | Conclusions Rho-Kinase activity is markedly increased in patients with stable chronic HF under optimal medical treatment, and it is associated with pathologic LV remodeling and systolic dysfunction. Mechanisms of Rho-kinase activation in patients with HF, its role in the progression of the disease, and the direct effect of Rho-kinase inhibition need further investigation. (Am Heart J 2011;161:931-7.) | |
dc.fechaingreso.objetodigital | 2024-03-19 | |
dc.format.extent | 7 páginas | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1016/j.ahj.2011.01.024 | |
dc.identifier.issn | 0002-8703 | |
dc.identifier.pubmedid | MEDLINE:21570525 | |
dc.identifier.uri | https://doi.org/10.1016/j.ahj.2011.01.024 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/79517 | |
dc.identifier.wosid | WOS:000290559300025 | |
dc.information.autoruc | Medicina; Jalil J;S/I;99946 | |
dc.information.autoruc | Medicina;Braun S ;S/I;102911 | |
dc.information.autoruc | Medicina;Castro P ;S/I;100212 | |
dc.information.autoruc | Medicina;Cordova S ;S/I;96819 | |
dc.information.autoruc | Medicina;Gabrielli L ;S/I;11086 | |
dc.information.autoruc | Medicina;Godoy I;S/I;70048 | |
dc.information.autoruc | Ciencias Biológicas;Novoa U ;S/I;1000353 | |
dc.information.autoruc | Medicina;Ocaranza M;S/I;1001254 | |
dc.issue.numero | 5 | |
dc.language.iso | en | |
dc.nota.acceso | Contenido parcial | |
dc.pagina.final | 937 | |
dc.pagina.inicio | 931 | |
dc.publisher | MOSBY-ELSEVIER | |
dc.revista | AMERICAN HEART JOURNAL | |
dc.rights | acceso restringido | |
dc.subject | PULMONARY ARTERIAL-HYPERTENSION | |
dc.subject | LONG-TERM INHIBITION | |
dc.subject | ECHOCARDIOGRAPHIC-ASSESSMENT | |
dc.subject | CARDIOVASCULAR MEDICINE | |
dc.subject | CARDIAC-HYPERTROPHY | |
dc.subject | ALDOSTERONE ESCAPE | |
dc.subject | AMERICAN-SOCIETY | |
dc.subject | DISEASE | |
dc.subject | RATS | |
dc.subject | LYMPHOCYTE | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Markedly increased Rho-kinase activity in circulating leukocytes in patients with chronic heart failure | |
dc.type | artículo | |
dc.volumen | 161 | |
sipa.codpersvinculados | 99946 | |
sipa.codpersvinculados | 102911 | |
sipa.codpersvinculados | 100212 | |
sipa.codpersvinculados | 96819 | |
sipa.codpersvinculados | 11086 | |
sipa.codpersvinculados | 70048 | |
sipa.codpersvinculados | 1000353 | |
sipa.codpersvinculados | 1001254 | |
sipa.index | WOS | |
sipa.index | Scopus | |
sipa.trazabilidad | Carga SIPA;09-01-2024 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 2024-03-19. Markedly increased Rho-kinase activity in circulating leukocytes in patients with chronic heart failure.pdf
- Size:
- 127.7 KB
- Format:
- Adobe Portable Document Format
- Description: